Chronic recreational physical inactivity and epithelial ovarian cancer risk: Evidence from the ovarian cancer association consortium

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 7, 2016, Pages 1114-1124

  Cannioto, Rikki ^a   LaMonte, Michael J ^b   Risch, Harvey A ^c   Hong, Chi Chen ^a   Sucheston Campbell, Lara E ^a   Eng, Kevin H ^a   Szender, J Brian ^a   Chang Claude, Jenny ^d,e   Schmalfeldt, Barbara ^e   Klapdor, Ruediger ^f   Gower, Emily ^a,b   Minlikeeva, Albina N ^a,b   Zirpoli, Gary R ^a   Bandera, Elisa V ^g   Berchuck, Andrew ^h   Cramer, Daniel ⁱ   Doherty, Jennifer A ^j   Edwards, Robert P ^k,l   Fridley, Brooke L ^m   Goode, Ellen L ⁿ   Goodman, Marc T ^o   Hogdall, Estrid ^p,q   Hosono, Satoyo ^r   Jensen, Allan ^p   Jordan, Susan ^s,t   Kjaer, Susanne K ^p,q   Matsuo, Keitaro ^r   Ness, Roberta B ^u   Olsen, Catherine M ^t   Olson, Sara H ^v   Pearce, Celeste Leigh ^w   Pike, Malcolm C ^v   Rossing, Mary Anne ^x   Szamreta, Elizabeth A ^g   Thompson, Pamela J ^o   Tseng, Chiu Chen ^y   Vierkant, Robert A ⁿ   Webb, Penelope M ^t   Wentzensen, Nicolas ^z   Wicklund, Kristine G ^x   Winham, Stacey J ⁿ   Wu, Anna H ^y   Modugno, Francesmary ^k,l,aa   Schildkraut, Joellen M ^ab   Terry, Kathryn L ⁱ   Kelemen, Linda E ^ac   Moysich, Kirsten B ^a   more..

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c YALE UNIVERSITY   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j DARTMOUTH MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF PITTSBURGH   (United States)

^m UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

ⁿ MAYO CLINIC   (United States)

^o CEDARS SINAI MEDICAL CENTER   (United States)

^p DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^q UNIVERSITY OF COPENHAGEN   (Denmark)

^r AICHI CANCER CENTER HOSPITAL   (Japan)

^s PETER MACCALLUM CANCER CENTRE   (Australia)

^t QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^u UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^v MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^w UNIVERSITY OF MICHIGAN   (United States)

^x USA   (United States)

^y UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^z NATIONAL CANCER INSTITUTE   (United States)

^aa UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^ab UNIVERSITY OF VIRGINIA   (United States)

^ac MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMERICAN; ARTICLE; BODY MASS; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MENOPAUSE; OVARY CARCINOMA; PHYSICAL INACTIVITY; POPULATION BASED CASE CONTROL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE; RECREATION; SEDENTARY LIFESTYLE; SELF REPORT; CASE CONTROL STUDY; EXERCISE; META ANALYSIS; NEOPLASM; OVARY TUMOR; PHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL;

ADULT; CASE-CONTROL STUDIES; EXERCISE; FEMALE; HUMANS; LOGISTIC MODELS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RECREATION; RISK FACTORS; SEDENTARY LIFESTYLE;

EID: 84977071152     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-1330     Document Type: Article

References (73)

1. Friedenreich CM, Neilson HK, Lynch BM. State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 2010;46:2593-604
2. Kruk J, Czerniak U. Physical activity and its relation to cancer risk: updating the evidence. Asian Pac J Cancer Prev 2013;14:3993-4003
3. Cannioto RA, Moysich KB. Epithelial ovarian cancer and recreational physical activity: a review of the epidemiological literature and implications for exercise prescription. Gynecol Oncol 2015;137: 559-73
4. WCRF/AICR. Food, Nutrition, Physical Activity, and the Prevention of Ovarianc Cancer 2014. Continuous update project report ovarian cancer 2014 summary . Available from: http://www.aicr.org/continuous-updateproject/ reports/ovarian-cancer-2014-report.pdf
5. United States Department of Health &Human Services. 2008 physical activity guidelines for Americans . Washington, D.C.: Office of Disease Prevention and Health Promotion; 2008
6. Olsen CM, Bain CJ, Jordan SJ, Nagle CM, Green AC, Whiteman DC, et al. Recreational physical activity and epithelial ovarian cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 2007;16:2321-30
7. Moorman PG, Jones LW, Akushevich L, Schildkraut JM. Recreational physical activity and ovarian cancer risk and survival. Ann Epidemiol 2011;21:178-87
8. Bull FC, Armstrong TP, Dixon T, Ham S, Neiman A, Pratt M. Physical inactivity. Comparitive quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva, Switzerland: WHO; 2004. p. 729-881
9. Huang T, Eliassen AH, Hankinson SE, OkerekeOI, Kubzansky LD, Wang M, et al. A prospective study of leisure-time physical activity and risk of incident epithelial ovarian cancer: impact by menopausal status. Int J Cancer 2016;138:843-52
10. Leitzmann MF, Koebnick C, Moore SC, Danforth KN, Brinton LA, Hollenbeck AR, et al. Prospective study of physical activity and the risk of ovarian cancer. Cancer Causes Control 2009;20:765-73
11. Troiano R. Limitations of self-report in physical activity and obesity research. In: Bouchard C, Katzmarzyk PT, editors. Physical activity and obesity , 2nd Edition. Champaign, IL: Human Kinetics; 2010:34-7
12. Troiano RD, Dodd KW. Differences between objective and self-report measures of physical activity. What do they mean? J Kor Soc Meas Eval 2008;10:31-42
13. Tudor-Locke CE, Myers AM. Challenges and opportunities for measuring physical activity in sedentary adults. Sports Med 2001;31:91-100
14. Moore LV, Harris CD, Carlson SA, Kruger J, Fulton JE. Trends in no leisuretime physical activity-United States, 1988-2010. Res Q Exerc Sport 2012;83:587-91
15. Sanchis-Gomar F, Lucia A, Yvert T, Ruiz-Casado A, Pareja-Galeano H, Santos-Lozano A, et al. Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis. Cancer Prev Res 2015;8: 105-10
16. Celis-Morales CA, Perez-Bravo F, Ibanez L, Salas C, Bailey ME, Gill JM. Objective vs. self-reported physical activity and sedentary time: effects of measurement method on relationships with risk biomarkers. PLoS One 2012;7:e36345
17. Fiuza-Luces C, Garatachea N, Berger NA, Lucia A. Exercise is the real polypill. Physiology 2013;28:330-58
18. Bandera EV, King M, Chandran U, Paddock LE, Rodriguez-Rodriguez L, Olson SH. Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Womens Health 2011;11:40
19. Goodman MT, Lurie G, Thompson PJ, McDuffie KE, Carney ME. Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk. Endocr Relat Cancer 2008;15:1055-60
20. Ness RB, Dodge RC, Edwards RP, Baker JA, Moysich KB. Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Ann Epidemiol 2011;21:188-96
21. Pike MC, Pearce CL, Peters R, Cozen W, Wan P, Wu AH. Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. Fertil Steril 2004;82:186-95
22. Risch HA, Bale AE, Beck PA, Zheng W. PGR and thorn 331 A/G and increased risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2006;15: 1738-41
23. Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2548-56
24. Terry KL, De Vivo I, Titus-Ernstoff L, Shih MC, Cramer DW. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Cancer Res 2005;65:5974-81
25. Merritt MA, Green AC, Nagle CM, Webb PM. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer 2008;122:170-6
26. Glud E, Kjaer SK, Thomsen BL, Hogdall C, Christensen L, Hogdall E, et al. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 2004;164:2253-9
27. Faber MT, Kjaer SK, Dehlendorff C, Chang-Claude J, Andersen KK, Hogdall E, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes Control 2013;24:989-1004
28. Kelemen LE, Bandera EV, Terry KL, Rossing MA, Brinton LA, Doherty JA, et al. Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the ovarian cancer association consortium. BMC Cancer 2013;13:28
29. Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer 2013;20:251-62
30. Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012;13:385-94
31. Sieh W, Salvador S,McGuire V, Weber RP, Terry KL, Rossing MA, et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of casecontrol studies. Int J Epidemiol 2013;42:579-89
32. Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, et al. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prev Res 2013;6:811-21
33. Trabert B, Ness RB, Lo-CiganicWH, Murphy MA, Goode EL, Poole EM, et al. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the ovarian cancer association consortium. J Natl Cancer Inst 2014;106: djt431
34. Szklo M, Nieto J. Indentifying non causal associations: confounding. In: Szklo M, Nieto J, editors. Epidemiology: beyond the basics . Sudbury, MA: Jones &Bartlett Learning; 2007:151-82
35. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993;138:923-36
36. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60
37. DerSimonian R, LairdN.Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88
38. Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet 2012;380:247-57
39. Patel AV, Hildebrand JS, Campbell PT, Teras LR, Craft LL, McCullough ML, et al. Leisure-time spent sitting and site-specific cancer incidence in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev 2015;24:1350-9
40. Patel AV, Rodriguez C, Pavluck AL, Thun MJ,Calle EE.Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women. Am J Epidemiol 2006;163:709-16
41. Xiao Q, Yang HP, Wentzensen N, Hollenbeck A, Matthews CE. Physical activity in different periods of life, sedentary behavior, and the risk of ovarian cancer in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 2013;22:2000-8
42. Zhang M, Xie X, Lee AH, Binns CW. Sedentary behaviours and epithelial ovarian cancer risk. Cancer Causes Control 2004;15:83-9
43. Hildebrand JS, Gapstur SM,GaudetMM,Campbell PT, Patel AV.Moderateto-vigorous physical activity and leisure-time sitting in relation to ovarian cancer risk in a large prospective US cohort. Cancer Causes Control 2015;26:1691-7
44. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, et al. Position statement. Part one: immune function and exercise. Exerc Immunol Rev 2011;17:6-63
45. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999;91:1459-67
46. Kasapis C, Thompson PD. The effects of physical activity on serum Creactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005;45:1563-9
47. Dupont J, Reverchon M, Cloix L, Froment P, Rame C. Involvement of adipokines, AMPK, PI3K and the PPAR signaling pathways in ovarian follicle development and cancer. Int J Dev Biol 2012;56:959-67
48. Mor G, Visintin I, Lai Y, Zhao H, Schwartz P, Rutherford T, et al. Serum proteinmarkers for early detection of ovarian cancer. Proc Natl Acad SciUS A 2005;102:7677-82
49. Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y, et al. Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res 2008;14:1065-72
50. Cuello-Fredes M, Kato S, Abarzua-Catalan L, Delpiano A, Trigo C, Garcia K, et al. Leptin promotes a more aggresive behavior of ovarian cancer cells: a potential explanation for a worse prognosis in obese ovarian cancer patients: igcs-0095 ovarian cancer. Int J Gynecol Cancer 2015;25 Suppl 1:S67
51. Diaz ES, Karlan BY, Li AJ. Obesity-associated adipokines correlate with survival in epithelial ovarian cancer. Gynecol Oncol 2013;129: 353-7
52. Wu MM, Chen HC, Chen CL, You SL, Cheng WF, Chen CA, et al. A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels. PLoS One 2014;9:e104630
53. Okwan-Duodu D, Umpierrez GE, Brawley OW, Diaz R. Obesity-driven inflammation and cancer risk: role ofmyeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res 2013;3:21-33
54. Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, et al. Large-scale evaluation of common variation in regulatory T cellrelated genes and ovarian cancer outcome. Cancer Immunol Res 2014;2:332-40
55. Godoy HE, Khan AN, Vethanayagam RR, Grimm MJ, Singel KL, Kolomeyevskaya N, et al. Myeloid-derived suppressor cells modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice. PLoS One 2013;8:e69631
56. Govindaraj C, Scalzo-Inguanti K, Madondo M, Hallo J, Flanagan K, Quinn M, et al. Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2 and thorn Tregs within the tumor microenvironment. Clin Immunol 2013;149:97-110
57. Obermajer N, Muthuswamy R, Odunsi K, Edwards RP, Kalinski P. PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res 2011;71:7463-70
58. NockN, Berger NA. Obesity and cancer: overview of mechanisms. In: Berger N, editor. Cancer and energy balance, epidemiology and overview : New York, NY: Springer; 2010:129-79
59. Byers T. Physical activity and gastric cancer: so what? An epidemiologist's confession. Cancer Prev Res 2014;7:9-11
60. Lynch BM. Sedentary behavior and cancer: a systematic review of the literature and proposed biological mechanisms. Cancer Epidemiol Biomarkers Prev 2010;19:2691-709
61. Li S, Carlson E, Holm K. Validation of a single-item measure of usual physical activity. Percept Mot Skills 2000;91:593-602
62. Milton K, Bull FC, Bauman A. Reliability and validity testing of a singleitem physical activity measure. Br J Sports Med 2011;45:203-8
63. Rose S, Elley CR, Lawton BA, Dowell AC. A single question reliably identifies physically inactive women in primary care. N Z Med J 2008;121:U2897
64. Schechtman KB, Barzilai B, Rost K, Fisher EBJr.Measuring physical activity with a single question. Am J Public Health 1991;81:771-3
65. Smith BJ, Marshall AL, Huang N. Screening for physical activity in family practice: evaluation of two brief assessment tools. Am J Prev Med 2005;29:256-64
66. Weiss TW, Slater CH, Green LW, Kennedy VC, Albright DL, Wun CC. The validity of single-item, self-assessment questions as measures of adult physical activity. J Clin Epidemiol 1990;43:1123-9
67. Rothman K, Greenland S, Lash TL. Validity in Epidemiologic Studies. In: Rothman K, Greenland S, Lash TL, editors. Modern epidemiology , 3rd Edition. Philadelphia, PA: Wolters Kluwer/LippincottWilliams and Wilkins; 2012:128-47
68. Zhong S, Chen L, Lv M, Ma T, Zhang X, Zhao J. Nonoccupational physical activity and risk of ovarian cancer: a meta-analysis. Tumour Biol 2014;35:11065-73
69. Anderson JP, Ross JA, Folsom AR. Anthropometric variables, physical activity, and incidence of ovarian cancer: the iowa women's health study. Cancer 2004;100:1515-21
70. Chionh F, Baglietto L, Krishnan K, English DR, MacInnis RJ, Gertig DM, et al. Physical activity, body size and composition, and risk of ovarian cancer. Cancer Causes Control 2010;21:2183-94
71. Bodelon C, Cushing-Haugen KL, Wicklund KG, Doherty JA, Rossing MA. Sun exposure and risk of epithelial ovarian cancer. Cancer Causes Control 2012;23:1985-94
72. Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB. Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology 2012;23:311-9
73. Wu AH, Pearce CL, Tseng CC, Pike MC. African Americans and hispanics remain at lower risk of ovarian cancer than non-hispanic whites after considering nongenetic risk factors and oophorectomy rates. Cancer Epidemiol Biomarkers Prev 2015;24:1094-100